Inside Washington: Costs and Controls Challenge Manufacturers

BioPharm International, BioPharm International-02-01-2002, Volume 15, Issue 2
Pages: 52-56

By Jill Wechsler, pp. 52-56. More curbs on reimbursement for expensive, cutting-edge therapies may shape R&D programs and industry growth